1. Discontinuation of calcineurin inhibitors in heart transplant patients with end stage renal insufficiency as an alternative model of immunosuppression.
- Author
-
Jerzy S, Wierzbicki K, Kapelak B, Konstanty J, Przybyłowski P, Wójcik S, Drwiła R, Wróbel K, and Piatek J
- Subjects
- Adult, Aged, Calcineurin metabolism, Cyclosporine administration & dosage, Dose-Response Relationship, Drug, Follow-Up Studies, Glomerular Filtration Rate drug effects, Graft Rejection drug therapy, Graft Rejection immunology, Humans, Immune Tolerance drug effects, Immunosuppressive Agents administration & dosage, Immunosuppressive Agents adverse effects, Male, Middle Aged, Mycophenolic Acid administration & dosage, Renal Insufficiency, Chronic physiopathology, Renal Insufficiency, Chronic prevention & control, Retrospective Studies, Treatment Outcome, Calcineurin Inhibitors, Cyclosporine adverse effects, Heart Transplantation immunology, Immunosuppression Therapy methods, Mycophenolic Acid analogs & derivatives, Renal Insufficiency, Chronic chemically induced
- Abstract
Five heart recipients were followed up with mycophenolate mofetil and low dose cyclosporine due to progressive severe chronic postcyclosporine renal failure. Cyclosporine was gradually withdrawn and finally eliminated from immunosuppressive regimen to slow the rate of renal function loss. Improvement of renal function was observed. In the follow up after cyclosporine elimination no risk increase of acute rejection and no deterioration of left ventricle function was observed. Non-calcineurin inhibitors model in heart recipients can be the treatment of choice (but only in very selective cases) in patients with severe chronic renal insufficiency.
- Published
- 2006